A chronic disease is a disease that is long-lasting or recurrent. Examples of chronic diseases include inflammatory bowel disease, rheumatoid arthritis, type 1 diabetes, gout, asthma, autoimmune hepatitis, ankylosing spondylitis.
First-degree relatives of patients who develop coronary heart disease at a young age have twice the heart disease risk because of shared lifestyle risk factors and genetic predisposition.
A multi-faceted study looking at different aspects of Inflammatory Bowel disease in children and young adolescents including; disease outcomes, disease patterns, genetics and the development of new and better ways to monitor progress over time.
There is a major disparity between Maori and non-Maori in cardiovascular mortality, and currently the available data on cardiovascular disease in Maori has mostly been obtained from mortality (death rates) or hospital statistics.
The NZFBCS has the key goal of better understanding DNA sequence changes in genes that alter the risk of developing breast cancer through cutting-edge research with cancer experts from around the world.
Gene testing is a powerful tool to assist clinicians in deciding the best approach for managing children and family members who may be predisposed to retinoblastoma.
We are looking at health and developmental outcomes in young adulthood for New Zealand children born in 1986 who were born very early (premature) or of very low birthweight (less than 1500 grams)
The Nortika study is a trial assessing the pain killing effect of a medicine (nortriptyline) for people with knee arthritis.
The purpose of the study is gain a greater understanding of how nutritional therapy affects gut inflammation during active Crohn’s disease. It will help us to further understand the impact nutritional therapy has in adults on disease inflammation, control of disease and quality of life.
This study will examine the safety of giving Tdap vaccination to pregnant women in Canterbury and look at the health of infants born to these mothers in their first year of life
VIDARIS is a double blind randomised placebo controlled trial investigating the effect of vitamin D supplementation on the incidence and/or severity of acute respiratory infections-colds and flu in adults.